Alnylam Pharmace. buy Wolf_of_WS
Start price
23.06.24
/
50%
€154.85
Target price
23.06.25
-
Performance (%)
35.23%
End price
24.06.24
€209.40
Summary
This prediction ended on 24.06.24 with a price of €209.40. With a performance of 35.23% the BUY prediction by Wolf_of_WS was a big success. Wolf_of_WS has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -4.258% | -4.258% | 27.595% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
According to Wolf_of_WS what are the pros and cons of Alnylam Pharmace. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Wolf_of_WS for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.